Insider trade

Boston Scientific (BSX): CEO reported a gift or transfer of 102K shares

Michael F Mahoney, CEO at Boston Scientific, reported a gift / transfer of 102K shares.

102K
Shares
Traded
Nov 4, 2026
Filed
Nov 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 7, 2026Company filing · Form 8-K · Cyber incidentReported a cybersecurity incident“As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation (the “ Company ”) identified a cybersecurity incident that affected certain of its information technology systems and resulted in a global disruption to the Company’s operations.”
  2. Sep 9, 2026CongressDisclosed sale of BSX — reported range $50,001 - $100,000
  3. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/J/1RO/130; Material Number: M001195270
  4. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/BERN/1RO/130; Material Number: M001195440
  5. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/027/BERN/1RO/155; Material Number: M001195750
  6. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/TRANSEND/021/BERN/1RO/130; Material Number: M001195840
  7. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/SWAN/1RO/130; Material Number: M001195500
  8. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/155; Material Number: M001195310
  9. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/021/BERN/1RO/130; Material Number: M001195640
  10. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/027/J/1RO/155; Material Number: M001195480
  11. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/2RO/155; Material Number: M001195330
  12. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/STRAIGHT/1RO/130; Material Number: M001195210
  13. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/J/1RO/155; Material Number: M001195280
  14. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/SWAN/1RO/130; Material Number: M001195300
  15. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/SINGLE/021/BERN/1RO/105; Material Number: M001195230
  16. Sep 16, 2026FDARecall: Direxion Torqueable Microcatheter, NGMC/FATHOM/021/BERN/2RO/130; Material Number: M001195670
  17. Sep 21, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 21, 2026, Arthur C. Butcher informed Boston Scientific Corporation (the “Company”) that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January 1, 2027.”
  18. Sep 30, 2026FDARecall: Nalu TD2 Therapy Disc with firmware, REF: 34014-001, and TD2 Patient Kit, REF: 74011, part of the Nalu Neurostimulation System
  19. Oct 1, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On October 7, 2026, Boston Scientific Corporation (the “Company”) announced that Joe Fitzgerald, who currently serves as Executive Vice President and Group President, Cardiovascular, has been promoted to Executive Vice President and Chief Operating Officer of the Company, effective as of January 1, 2027.”
  20. Oct 1, 2026Federal contract · $1.0M obligatedDepartment of Veterans Affairs awarded Boston Scientific: $1.05M obligated to date
  21. Oct 1, 2026Federal contract · $880K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $880K obligated to date
  22. Oct 1, 2026Federal contract · $832K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $832K obligated to date
  23. Oct 1, 2026Federal contract · $524K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $524K obligated to date
  24. Oct 1, 2026Federal contract · $465K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $465K obligated to date
  25. Oct 28, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. Nov 17, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On November 17, 2026, upon the recommendation of the Executive Compensation and Human Resources Committee (the “Compensation Committee”), the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) approved the Company’s 2027 Annual Bonus Plan effective for the performance year of January 1, 2027 through December 31, 2027 (the “2027 Annual Bonus Plan”).”
  2. Nov 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Michael F Mahoney, Chairman, President & CEO

The full history of Michael F Mahoney, Chairman, President & CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Boston Scientific (BSX) insider traded, and how much?

Michael F Mahoney, CEO at Boston Scientific, reported a gift / transfer of 102K shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Nov 4, 2026. Filed: Nov 6, 2026. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Boston Scientific recently?

For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.

Does this mean BSX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data